vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $148.5M, roughly 1.6× OPKO HEALTH, INC.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -21.1%, a 25.5% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs -19.2%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $-28.6M). Over the past eight quarters, CSW INDUSTRIALS, INC.'s revenue compounded faster (5.1% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

CSW vs OPK — Head-to-Head

Bigger by revenue
CSW
CSW
1.6× larger
CSW
$233.0M
$148.5M
OPK
Growing faster (revenue YoY)
CSW
CSW
+39.5% gap
CSW
20.3%
-19.2%
OPK
Higher net margin
CSW
CSW
25.5% more per $
CSW
4.4%
-21.1%
OPK
More free cash flow
CSW
CSW
$51.3M more FCF
CSW
$22.7M
$-28.6M
OPK
Faster 2-yr revenue CAGR
CSW
CSW
Annualised
CSW
5.1%
-7.5%
OPK

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CSW
CSW
OPK
OPK
Revenue
$233.0M
$148.5M
Net Profit
$10.3M
$-31.3M
Gross Margin
39.7%
43.1%
Operating Margin
7.4%
-25.8%
Net Margin
4.4%
-21.1%
Revenue YoY
20.3%
-19.2%
Net Profit YoY
-61.9%
-322.8%
EPS (diluted)
$0.62
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
OPK
OPK
Q4 25
$233.0M
$148.5M
Q3 25
$277.0M
$151.7M
Q2 25
$263.6M
$156.8M
Q1 25
$230.5M
$150.0M
Q4 24
$193.6M
$183.6M
Q3 24
$227.9M
$173.6M
Q2 24
$226.2M
$182.2M
Q1 24
$210.9M
$173.7M
Net Profit
CSW
CSW
OPK
OPK
Q4 25
$10.3M
$-31.3M
Q3 25
$40.7M
$21.6M
Q2 25
$40.9M
$-148.4M
Q1 25
$35.1M
$-67.6M
Q4 24
$26.9M
$14.0M
Q3 24
$36.1M
$24.9M
Q2 24
$38.6M
$-10.3M
Q1 24
$31.8M
$-81.8M
Gross Margin
CSW
CSW
OPK
OPK
Q4 25
39.7%
43.1%
Q3 25
43.0%
32.9%
Q2 25
43.8%
31.5%
Q1 25
44.2%
28.4%
Q4 24
41.4%
46.1%
Q3 24
45.6%
23.1%
Q2 24
47.5%
28.4%
Q1 24
44.4%
24.2%
Operating Margin
CSW
CSW
OPK
OPK
Q4 25
7.4%
-25.8%
Q3 25
20.5%
31.7%
Q2 25
20.8%
-38.3%
Q1 25
19.5%
-44.8%
Q4 24
15.3%
-18.0%
Q3 24
22.6%
8.2%
Q2 24
24.3%
-33.9%
Q1 24
21.0%
-41.2%
Net Margin
CSW
CSW
OPK
OPK
Q4 25
4.4%
-21.1%
Q3 25
14.7%
14.3%
Q2 25
15.5%
-94.7%
Q1 25
15.2%
-45.1%
Q4 24
13.9%
7.6%
Q3 24
15.8%
14.3%
Q2 24
17.1%
-5.7%
Q1 24
15.1%
-47.1%
EPS (diluted)
CSW
CSW
OPK
OPK
Q4 25
$0.62
$-0.04
Q3 25
$2.41
$0.03
Q2 25
$2.43
$-0.19
Q1 25
$2.05
$-0.10
Q4 24
$1.60
$0.02
Q3 24
$2.26
$0.03
Q2 24
$2.47
$-0.01
Q1 24
$2.03
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$40.2M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.1B
$1.3B
Total Assets
$2.3B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
OPK
OPK
Q4 25
$40.2M
$364.4M
Q3 25
$31.5M
$412.0M
Q2 25
$38.0M
$267.3M
Q1 25
$225.8M
$428.8M
Q4 24
$213.8M
$426.6M
Q3 24
$273.2M
$400.1M
Q2 24
$18.9M
$40.6M
Q1 24
$22.2M
$75.6M
Total Debt
CSW
CSW
OPK
OPK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$800.1M
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$166.0M
$350.1M
Stockholders' Equity
CSW
CSW
OPK
OPK
Q4 25
$1.1B
$1.3B
Q3 25
$1.1B
$1.3B
Q2 25
$1.1B
$1.3B
Q1 25
$1.1B
$1.3B
Q4 24
$1.0B
$1.4B
Q3 24
$1.0B
$1.4B
Q2 24
$650.2M
$1.4B
Q1 24
$615.7M
$1.3B
Total Assets
CSW
CSW
OPK
OPK
Q4 25
$2.3B
$1.9B
Q3 25
$1.5B
$2.0B
Q2 25
$1.5B
$2.0B
Q1 25
$1.4B
$2.1B
Q4 24
$1.4B
$2.2B
Q3 24
$1.4B
$2.3B
Q2 24
$1.1B
$2.0B
Q1 24
$1.0B
$2.0B
Debt / Equity
CSW
CSW
OPK
OPK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.75×
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.27×
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
OPK
OPK
Operating Cash FlowLast quarter
$28.9M
$-25.9M
Free Cash FlowOCF − Capex
$22.7M
$-28.6M
FCF MarginFCF / Revenue
9.8%
-19.3%
Capex IntensityCapex / Revenue
2.6%
1.8%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
OPK
OPK
Q4 25
$28.9M
$-25.9M
Q3 25
$61.8M
$-34.6M
Q2 25
$60.6M
$-83.4M
Q1 25
$27.3M
$-34.6M
Q4 24
$11.6M
$-44.4M
Q3 24
$66.8M
$-77.1M
Q2 24
$62.7M
$-26.4M
Q1 24
$22.4M
$-35.6M
Free Cash Flow
CSW
CSW
OPK
OPK
Q4 25
$22.7M
$-28.6M
Q3 25
$58.7M
$-37.8M
Q2 25
$57.7M
$-86.7M
Q1 25
$22.8M
$-37.7M
Q4 24
$8.5M
$-49.8M
Q3 24
$61.3M
$-85.0M
Q2 24
$59.6M
$-33.7M
Q1 24
$17.5M
$-40.0M
FCF Margin
CSW
CSW
OPK
OPK
Q4 25
9.8%
-19.3%
Q3 25
21.2%
-24.9%
Q2 25
21.9%
-55.3%
Q1 25
9.9%
-25.2%
Q4 24
4.4%
-27.1%
Q3 24
26.9%
-49.0%
Q2 24
26.3%
-18.5%
Q1 24
8.3%
-23.0%
Capex Intensity
CSW
CSW
OPK
OPK
Q4 25
2.6%
1.8%
Q3 25
1.1%
2.1%
Q2 25
1.1%
2.1%
Q1 25
2.0%
2.1%
Q4 24
1.6%
2.9%
Q3 24
2.4%
4.6%
Q2 24
1.4%
4.0%
Q1 24
2.3%
2.6%
Cash Conversion
CSW
CSW
OPK
OPK
Q4 25
2.81×
Q3 25
1.52×
-1.60×
Q2 25
1.48×
Q1 25
0.78×
Q4 24
0.43×
-3.17×
Q3 24
1.85×
-3.10×
Q2 24
1.62×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons